Ameriprise’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $377K | Buy |
+23,553
| New | +$377K | ﹤0.01% | 3590 |
|
|
2025
Q1 | – | Sell |
-8,907
| Closed | -$221K | – | 4049 |
|
|
2024
Q4 | $221K | Buy |
+8,907
| New | +$221K | ﹤0.01% | 3807 |
|
|
2024
Q3 | – | Sell |
-15,793
| Closed | -$417K | – | 3961 |
|
|
2024
Q2 | $417K | Sell |
15,793
-3,608
| -19% | -$95.3K | ﹤0.01% | 3477 |
|
|
2024
Q1 | $627K | Buy |
19,401
+5,751
| +42% | +$186K | ﹤0.01% | 3344 |
|
|
2023
Q4 | $575K | Buy |
13,650
+4,146
| +44% | +$175K | ﹤0.01% | 3403 |
|
|
2023
Q3 | $365K | Sell |
9,504
-1,990
| -17% | -$76.4K | ﹤0.01% | 3521 |
|
|
2023
Q2 | $218K | Buy |
11,494
+300
| +3% | +$5.69K | ﹤0.01% | 3706 |
|
|
2023
Q1 | $174K | Sell |
11,194
-1,625
| -13% | -$25.2K | ﹤0.01% | 3755 |
|
|
2022
Q4 | $228K | Buy |
+12,819
| New | +$228K | ﹤0.01% | 3672 |
|